SHH and medulloblastoma: Extensive genetic, epigenetic, and transcriptomic analyses have identified medulloblastoma as a heterogenous disease with four major molecular subgroups, namely wingless (WNT pathway-activated), sonic-hedgehog (SHH pathway-activated), Group 3 and Group 4 [3–5].